指南与共识泌尿生殖腹部CTMR

结节性硬化症相关肾血管平滑肌脂肪瘤的影像学诊断与管理建议

Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex.
指南 / 共识 · Clin Kidney J · 2017-09-11

结节性硬化症(TSC)患者中肾血管平滑肌脂肪瘤发生率高达80%,直径>3 cm的病灶易出血,多达10%的TSC患者可能发生大量且可能致命的腹膜后出血。诊断可因初期无症状及不典型肾血管平滑肌脂肪瘤乏脂肪含量而复杂化。多学科专家组基于当前证据和专业经验,针对成人和儿童TSC相关肾血管平滑肌脂肪瘤的影像学检查制定了一系列建议,涵盖典型与不典型或乏脂肪TSC相关肾血管平滑肌脂肪瘤的影像学诊断与随访、活检指征、影像申请与报告的最低要求以及CT和MRI推荐的技术特征与方案。

要点

  • TSC患者肾血管平滑肌脂肪瘤发生率高达80%,直径>3 cm的病灶易出血。
  • 多达10%的TSC患者可能发生大量且可能致命的腹膜后出血。
  • 不典型肾血管平滑肌脂肪瘤乏脂肪含量可使诊断复杂化。

核心结论

  • 影像学评估对于TSC相关肾血管平滑肌脂肪瘤的诊断与管理至关重要,目的在于检测和表征肿瘤、评估和检测并发症风险以及评估治疗反应,尤其是在接受mTOR抑制剂治疗的患者中。
  • 多学科专家组基于当前证据和专业经验制定了针对成人和儿童TSC相关肾血管平滑肌脂肪瘤影像学检查的一系列建议。

研究设计与样本

  • 多学科专家组基于当前证据和专业经验制定建议,涵盖成人和儿童TSC相关肾血管平滑肌脂肪瘤的影像学检查。

诊断标准与关键数值

  • 肾血管平滑肌脂肪瘤在高达80%的TSC患者中被发现。
  • 直径>3 cm的病灶易出血,多达10%的TSC患者可能发生大量且可能致命的腹膜后出血。
  • mTOR抑制剂治疗适用于TSC相关肾血管平滑肌脂肪瘤直径>3 cm的患者。
  • 建议涵盖典型与不典型或乏脂肪TSC相关肾血管平滑肌脂肪瘤的影像学诊断与随访、活检指征、影像申请与报告的最低要求以及CT和MRI推荐的技术特征与方案。

临床应用与阅片要点

  • 影像学检查用于检测和表征肿瘤、评估和检测并发症风险以及评估治疗反应,尤其是在接受mTOR抑制剂治疗的患者中。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Renal angiomyolipomas are found in up to 80% of tuberous sclerosis complex (TSC) patients. Although these tumours are usually asymptomatic, lesions >3 cm in diameter are prone to bleeding and up to 10% of TSC patients may experience a massive and potentially fatal retroperitoneal haemorrhage. Diagnosis can be complicated because of the initial lack of symptoms and the fat-poor content of atypical renal angiomyolipomas. After diagnosis, tumour growth and the emergence of new tumours must be monitored. Treatment with mammalian target of rapamycin (mTOR) inhibitors can reduce tumour size and is indicated in patients with TSC-associated renal angiomyolipomas >3 cm in diameter. Imaging-based assessment of kidney disease is essential to the diagnosis and management of patients with TSC. The aims of imaging studies in this context are to detect and characterize tumours, assess and detect the risk of complications and evaluate the response to treatment, especially in patients treated with mTOR inhibitors. A multidisciplinary expert panel developed a series of recommendations based on current evidence and professional experience for imaging studies in adults and children with TSC-associated renal angiomyolipoma. The recommendations cover radiological diagnosis and follow-up of the classic and atypical or fat-poor TSC-associated renal angiomyolipomas, biopsy indications, minimal requirements for radiological requests and reports and recommended technical features and protocols for computed tomography and magnetic resonance imaging.

来源:Clin Kidney J,查看原文。版权归原作者所有。

引用

  1. Buj Pradilla MJ, Martí Ballesté T, Torra R, et al. Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. Clin Kidney J. 2017. PMID: 29225800. doi:10.1093/ckj/sfx094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。